Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study

ConclusionsThe present study showed that administering ARB was significantly associated with a lower frequency of bone fracture history.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research